The United Kingdom has become the first nation to conditionally approve Moderna’s COVID-19 vaccine that targets both the original strain that kicked off the pandemic and a strain of the omicron variant.
Marketplace/August 16, 2022
The United Kingdom has become the first nation to conditionally approve Moderna’s COVID-19 vaccine that targets both the original strain that kicked off the pandemic and a strain of the omicron variant.
Marketplace/August 16, 2022